Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
Authors
Keywords
Breast Cancer, Cancer-testis Antigen, NY-BR-1, Immunotherapy, Prognosis
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-06-04
DOI
10.1186/1471-2407-13-271
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic and Predictive Markers for Treatment Decisions in Early Breast Cancer
- (2011) Elmar Stickeler Breast Care
- Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
- (2011) M. Rao et al. CANCER RESEARCH
- Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma
- (2011) Jin-xue Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers
- (2011) Yao-Tseng Chen et al. PLoS One
- Cancer-testis antigen expression in triple-negative breast cancer
- (2010) G. Curigliano et al. ANNALS OF ONCOLOGY
- Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors
- (2010) Daniel Perez et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer/testis (CT) antigens: Potential targets for immunotherapy
- (2009) Otavia L. Caballero et al. CANCER SCIENCE
- Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma
- (2009) D. Atanackovic et al. CLINICAL CANCER RESEARCH
- Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire
- (2009) G. Bioley et al. CLINICAL CANCER RESEARCH
- NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells
- (2009) S. Gnjatic et al. CLINICAL CANCER RESEARCH
- Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
- (2009) Kazumasa Hiroishi et al. JOURNAL OF GASTROENTEROLOGY
- CT-X antigen expression in human breast cancer
- (2009) A. Grigoriadis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAGE-A and NY-ESO-1 expression in cervical cancer: Prognostic factors and effects of chemotherapy
- (2008) Chiara Napoletano et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia
- (2008) X. Zhu et al. CLINICAL CANCER RESEARCH
- Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence
- (2008) Daniel Perez et al. INTERNATIONAL JOURNAL OF CANCER
- MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors
- (2008) Elena Grau et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now